APDA pledges $4M for Parkinson’s research, up 55% from 2024
The American Parkinson Disease Association (APDA) is providing $4.04 million for the 2025-2026 funding year to support research projects on…
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The American Parkinson Disease Association (APDA) is providing $4.04 million for the 2025-2026 funding year to support research projects on…
The Parkinson’s Foundation invites U.S. medical centers offering outstanding Parkinson’s disease clinical care and resources to join its…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $697,000 grant to a research project using…
Noninvasively stimulating a nerve in the leg using Stimvia‘s URIS device is feasible, safe, and may help reduce motor…
The Parkinson’s Foundation has launched a pilot program it hopes will make it easier for Parkinson’s disease patients who…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $5 million grant to Congruence Therapeutics to…
A five-year, $3.4 million grant from the National Institute of Environmental Health Sciences is supporting research into how manganese exposure…
S.Biomedics said its stem cell-based therapy A9-DPC was found safe and effective in improving motor function over a one-year follow-up…
Health Canada will review Knight Therapeutics’ application seeking approval of Crexont, an extended-release formulation of levodopa and carbidopa…
A research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will support a new study that’s…
Get regular updates to your inbox.